Bone marrow-derived mesenchymal stem cells for treatment of retinitis pigmentosa

The purpose of this study is to determine the feasibility and safety of intravitreal injection of adult human bone marrow-derived mesenchymal stem cell into patients with retinitis pigmentosa (RP).